lilly tirzepatide approval releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Lilly launches lower-price weight-loss drug

The ratio of ApoB-100 to ApoA-1 fell by 9% in the L

Cleanse your skin with an alcohol swab and wait 30 seconds for it to dry fully

As more plaintiffs file lawsuits, Mounjaro has become a major focus in the ongoing Ozempic litigation MDL

Patients with severe hepatic impairment (Child-Pugh class C) have not been extensively studied in clinical trials, and limited data exist regarding the safety and efficacy of semaglutide in this population

In truth, most of us could probably use a boost

People whose diabetes was recently diagnosed showed significant improvements in levels of HbA1c a measurement of blood sugar and their body weight